Publication Date:
2014-04-11
Description:
Resistance to the tyrosine kinase inhibitor axitinib is associated with increased glucose metabolism in pancreatic adenocarcinoma Cell Death and Disease 5, e1160 (April 2014). doi:10.1038/cddis.2014.125 Authors: C D Hudson, T Hagemann, S J Mather & N Avril
Keywords:
receptor tyrosine kinase inhibitorpancreatic adenocarcinomaPI3K/Aktglycolysisdrug resistancemolecular targeted therapies
Electronic ISSN:
2041-4889
Topics:
Biology
,
Medicine
Permalink